The Office of Research in the College of Medicine and Office of Health Sciences, led by Caroline Whitacre, PhD, is pleased to announce the establishment of the Office of Translational and Applied Research (OTAR) with the mission to address the barriers and facilitate the development of Translational and Applied Research at The Ohio State University Medical Center. The discipline, Translational and Applied Research serves as a powerful vehicle to connect the scientific community to the people whose health problems we have undertaken to solve. Strengths in the infrastructure for large-scale patient care, well-developed vehicles for community outreach, prospect for corporate partnership and extraordinary opportunities for interdisciplinary research in health sciences uniquely position OSUMC to emerge as a national leader in Translational and Applied Research.
OTAR plans to develop and strengthen translational research that aims to take fundamental discoveries to benefit people’s lives. Bench to bedside and back through the appropriate use of pre-clinical models and effective partnership between basic and clinical scientists represents the core of OTAR’s mission goal. Another key component of the mission is to provide students at all levels with support to familiarize themselves with the concept of translational research and novel career opportunities and to develop new policies and practices that support faculty involved in applied research. To speak to someone in the OTAR, please contact: Sandy Rees |
Chandan K. Sen, PhD, FACSM, FACN, will serve as the first Associate Dean of Translational and Applied Research at OSUMC. In addition to leading OTAR, Professor Sen has been appointed Chair of the Technology Commercialization Partnership Council (TCP). The TCP helps facilitate collaboration between The Ohio State University Medical Center faculty, researchers and inventors and the University’s Technology Licensing and Commercialization (TLC) team, as well as between the Medical Center and industry. The collective goal is the fostering of partnerships that bolster sponsored research and development, and the rapid commercialization of technologies created at the Medical Center via licensing and start-up formation.